Coloplast A/S (OTCMKTS:CLPBY) Rating Increased to Strong-Buy at Kepler Capital Markets

Kepler Capital Markets upgraded shares of Coloplast A/S (OTCMKTS:CLPBY) to a strong-buy rating in a report published on Wednesday morning,Zacks.com reports.

Other equities analysts have also issued reports about the company. The Goldman Sachs Group lowered Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Sanford C. Bernstein upgraded Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Coloplast A/S Trading Up 2.6%

Coloplast A/S stock opened at $6.62 on Wednesday. The stock has a market cap of $14.91 billion, a PE ratio of 47.26, a P/E/G ratio of 2.04 and a beta of 0.15. The stock has a 50-day moving average price of $6.61 and a 200 day moving average price of $7.83. Coloplast A/S has a 52 week low of $6.10 and a 52 week high of $10.03. The company has a current ratio of 1.30, a quick ratio of 0.81 and a debt-to-equity ratio of 1.50.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.09 by $0.01. The company had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.11 billion. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%. Equities research analysts predict that Coloplast A/S will post 0.4 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.